Not logged in
  Home   Markets   Shares   Funds   Portfolio   Toolbox   Charting   Alerts   Directory   
 Admin   

Wed 14 Mar 2012, 17:43 ACT/ACTP - AfroCentric Investment Corporation Limited - Unaudited Interim
ACT
ACT                                                                             
ACT/ACTP - AfroCentric Investment Corporation Limited - Unaudited Interim       
Results for the six months ended 31 December 2011                               
AfroCentric Investment Corporation Limited                                      
Registration number 1988/000570/06                                              
JSE Code: ACT, ACTP                                                             
ISIN: ZAE 000078416, ZAE 000082269                                              
("AfroCentric" or "the Company" or "the Group")                                 
Unaudited Interim Results for the six months ended 31 December 2011             
Headlines                                                                       
Earnings per share                      16% up                                  
Diluted earnings per share              15% up                                  
Headline earnings per share             13% up                                  
Diluted headline earnings per share     12% up                                  
CONDENSED CONSOLIDATED STATEMENT OF FINANCIAL POSITION                          
                                       Unaudited Unaudited Audited              
six months     six months     year       
                                       ended     ended     ended                
                                  31 Dec 2011    31 Dec 2010    30 Jun 2011     
                                            R`000     R`000     R`000           
ASSETS                                                                          
Non-current assets                           941,838   970,061   951,923        
Property, plant and equipment                100,048   118,169   101,083        
Investment property                          10,100    8,543     10,100         
Intangible assets                            609,926   592,865   609.552        
Unlisted investments                         280       280       280            
Investment in associates                     62,368    64.796    63,859         
Investment in preference shares              100,000   100,000   100,000        
Deferred income tax assets                   59,116    85,408    67,049         
Current assets                               241,966   209,517   291,064        
Trade and other receivables                  94,685    98,706    93,010         
Receivables from associates                                                     
and joint venture                            18,647    15,586    18,039         
Current tax asset                            7,981          -         -         
Cash and cash equivalents                    120,653   95,225    180,015        
Total assets                                 1,183,804 1,179,578 1,242,987      
EQUITY AND LIABILITIES                                                          
Capital and reserves                         758,355   670,268   726,850        
Issued capital                               347,716   393.181   372,060        
Contingent shares to be issued               188,540   188,540   188,540        
Treasury shares                              (1,162)   (610)     (1,162)        
Foreign currency translation reserve         (327)     (462)     241            
Distributable reserve                        223,588   89,619    167,171        
Minority interest                            17,694    25,021    20.786         
Total equity                                 776,049   695,289   747,636        
Non-current liabilities                      270,376   346,550   304,129        
Deferred income tax liabilities              35,031    39,698    37,273         
Borrowings                                   200,000   200,000   200,000        
Provisions                                   9,215     67,575    41,600         
Post-employment medical obligations          3,821     3,866     3,821          
Accrual for straight lining of leases        22,309    35,411    21,435         
Current liabilities                          137,379   137,739   191,222        
Provisions                                   2,073     2,790     20,378         
Trade and other payables                     69,953    67,515    76,334         
Taxation                                     4,239     3,540     8,495          
Bank overdraft                               9,087     15,245    7,304          
Employment benefit provisions                52,026    48,649    78,711         
Total liabilities                            407,755   484,289   495,351        
Total equity and liabilities                 1,183,804 1,179,578 1,242,987      
         -    -    -                                                            
CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME                        
                                            Unaudited Unaudited Audited         
                                       six months     six months     year       
                                            ended     ended     ended           
%    31 Dec 2011    31 Dec 2010    30 Jun 2011     
                                  change    R`000     R`000     R`000           
Revenue                                      670,007   672,088   1,351,254      
Operating costs                              (566,807) (579,641) (1,128,141)    
Operating profit                             103,201   92,447    223,113        
Other income                                 10,965    15,714    31,978         
Net finance cost                             (1,701)   1,434     1,478          
Share of profit from associates              4,906     2,211     10,888         
Profit before impairment                                                        
and amortisation                             117,370   111,806   267,457        
Impairment of investment                          -         -    (10,266)       
Impairment of intangible assets                   -    (996)     (4,958)        
Depreciation                                 (19,294)  (24,062)  (44,170)       
Amortisation of intangible assets            (17,359)  (14,760)  (35,542)       
Profit before income tax                     80,718    71,988    172,521        
Income tax expense                           (21,783)  (21,166)  (45,982)       
Total comprehensive income                                                      
for the period                               58,935    50,822    126,539        
Attributable to:                                                                
Equity holders of the Parent            16   54,344    46,704    117,248        
Non-controlling interest                     4,591     4,118     9,291          
                                       16   58,935    50,822    126,539         
CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN EQUITY                           
                                            Unaudited Unaudited Audited         
six months     six months     year       
                                            ended     ended     ended           
                                  31 Dec 2011    31 Dec 2010    30 Jun 2011     
                                            R`000     R`000     R`000           
Balance at beginning of the period           747,636   642,063   642,063        
Issue of share capital                       3,929     3,741     5,996          
Treasury shares revalued                               -    -    (552)          
Foreign currency translation reserve         (568)     (462)     241            
Distributions to shareholders                (33,883)  (875)     (26,651)       
Income attributable to equity                                                   
holders of the parent                        54,344    46,704    117,248        
Income attributable to minorities            4,591     4,118     9,291          
Balance at end of period                     776,049   695,289   747,636        
CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS                                  
                                       Unaudited Unaudited Audited              
                                       six months     six months     year       
ended     ended     ended           
                                  31 Dec 2011    31 Dec 2010    30 Jun 2011     
                                            R`000     R`000     R`000           
Net cash generated / (utilised)                                                 
in operating activities                      (11,947)  (29,196)  103,993        
Net cash inflow / (outflow)                                                     
from investing activities                    (24,854)  (43,289)  (88,869)       
Net cash inflow /                                                               
(outflow) from financing activities          (24,344)  37,928    43,050         
Net cash flow from continuing                                                   
operations                                   (61,145)  (34,557)  58,174         
Net (decrease)/increase                                                         
in cash and cash equivalents                 (61,145)  (34,557)  58,174         
Cash and cash equivalents at                                                    
beginning of the period                      172,711   114,537   114,537        
Cash and cash equivalents at                                                    
end of the period                            111,566   79,980    172,711        
Reconciled as follows:                                                          
Cash and cash equivalents on hand            120,653   95,225    180,015        
Bank overdraft                               (9,087)   (15,245)  (7,304)        
111,566   79,980    172,711         
EARNINGS ATTRIBUTABLE TO EQUITY HOLDERS                                         
                                            Unaudited Unaudited Audited         
                                       six months     six months     year       
ended     ended     ended      
                             %    31 Dec 2011    31 Dec 2010    30 Jun 2011     
                                       change    R`000     R`000     R`000      
Number of ordinary shares                                                       
in issue                           267,458,718    264,920,135    265,947,672    
Number of preference shares                                                     
in issue                           16,638,000     16,638,000     16,638,000     
Weighted average number of                                                      
ordinary shares                    265,332,341    263,744,652    264,561,839    
Weighted average number of                                                      
ordinary shares and                                                             
potential ordinary shares          312,530,939    310,056,281    311,493,781    
Basic earnings                          54,344    46,704         117,248        
Adjusted by:                                                                    
- Fair value gains                           -         -         (4,466)        
- Impairment of property, plant                                                 
and equipment                                -         -         -    146       
- Impairment of intangible assets            -         996            4,958     
- Impairment of investment in associate      -         -              10,266    
- Profit on disposal of assets          (166)          -         (1,226)        
- Reversal of loan impairments               (137)     -                   -    
Headline earnings                            54,041    47,700    126,926        
Earnings per share (cents)                                                      
- Attributable to ordinary                                                      
shares (cents)                               16   20.48     17.71     44.32     
- Diluted earnings per                                                          
share (cents)                                15   17.39     15.06     37.64     
Headline earnings per                                                           
share (cents)                                                                   
- Attributable to ordinary                                                      
shares (cents)                               13   20.37     18.09     47.98     
- Diluted earnings per                                                          
share (cents)                                12   17.29     15.38     40.75     
SEGMENTAL ANALYSIS                                                              
                                            Unaudited interim results           
                                       for the six months ended 31 Dec 2011     
Revenue   Profit    Total           
                                                      before tax     assets     
                                                 R`000     R`000     R`000      
Healthcare administration               670,007   72,152         806,941        
Electronics                                  -    2,650               -         
Treasury activities                          -    284            110,517        
Other - including inter-segment                                                 
elimination                                       -    5,631     266,346        
670,007   80,718    1,183,804            
                                                 Unaudited interim results      
                                       for the six months ended 31 Dec 2010     
                                                 Revenue   Profit    Total      
before tax     assets     
                                                 R`000     R`000     R`000      
Healthcare administration                    672,088   60,545    787,687        
Electronics                                       -    1,081          -         
Treasury activities                               -    4,182     110,208        
Other - including inter-segment                                                 
elimination                                       -    6,180     281,684        
                                            672,088   71,988    1,179,579       
Audited results      
                                            for the year ended 30 Jun 2011      
                                                 Revenue   Profit    Total      
                                                      before tax     assets     
R`000     R`000     R`000      
Healthcare administration               1,351,254      185,092   874,384        
Electronics                                  -         2,147          -         
Treasury activities                          -         8,049      110,272       
Other - including inter-segment                                                 
elimination                                  -    (22,767)       258,331        
                                       1,351,254    172,521     1,242,987       
COMMENTARY                                                                      
Introduction                                                                    
The Board of Directors has pleasure in presenting the Group`s interim           
results for the six month period ended 31 December 2011.                        
While the group is able to report a satisfactory increase in comparative        
earnings for the period under review, given the variety of once-off benefits    
and costs related to the acquisition and incorporation of Old Mutual            
Healthcare and the sale of Medscheme Life, an exact comparison with the 6       
months ending December 2010 does not convey the now more efficient delivery     
platform which the group`s subsidiary, Lethimvula Investments Limited           
("LIL") is today.                                                               
Accounting policies and basis of preparation                                    
The condensed consolidated financial statements for the six months ended 31     
December 2011 are prepared in accordance with International Financial           
Reporting Standards ("IFRS"), International Accounting Standard 34, The JSE     
Limited Listings Requirements, the South African Companies Act 71 of 2008 as    
amended and AC 500 Standards as issued by the Accounting Practices Board or     
its successor. The condensed consolidated interim financial statements are      
prepared on the historical cost basis and the accounting policies are           
consistent with those adopted and applied for the year ended 30 June 2011 in    
terms of IFRS.                                                                  
Nature of business                                                              
AfroCentric is a black owned diversified investment holding company, its        
major investments being in healthcare administration, electronics and the       
communications industries. AfroCentric also has a co-operation agreement        
with Rio Tinto Plc for mineral prospecting and exploration projects. The        
Company`s subsidiary, LIL, owns 100% of the shares in Medscheme Holdings        
(Pty) Limited, a multi medical scheme administrator. Medscheme is the           
largest black-owned medical scheme administrator in South Africa covering       
approximately 3 million lives in the private healthcare administration          
market.                                                                         
The company`s associate, Jasco Electronics Holdings Limited ("Jasco")           
provides communications, industrial and energy solutions, services and          
products to a broad range of customers.                                         
Operational review                                                              
LIL`s operating profits amounted to R72 million during the period under         
review (2010: R61 million). The improved profitability arises primarily from    
continuous efficiency improvements in the administration business. LIL`s        
administration and managed care contracts are reviewed in January of each       
year and accordingly profits of the healthcare division are favourably          
weighted toward the period January-June. LIL`s performance for the period is    
substantially on target with management forecast expectations for the 2012      
financial year.                                                                 
LIL continues to generate strong operating cash flows. It is important to       
note that within the net cash generated from operating activities is an         
outflow of R53.7 million relating to the termination of an onerous property     
lease agreement. The extrication from this onerous contract will yield          
positive cash flow benefits in future periods to 2013.                          
AfroCentric continues to acquire LIL shares from the minority shareholders      
who approach the Company to sell their shares. During the period AfroCentric    
acquired a further 6 151 099 LIL shares (1,1%) to bring the Company`s           
ownership of the issued share capital of LIL to 92,63%.                         
AfroCentric`s investment in listed Jasco yielded earnings and investment        
income for the six months ended 31 December 2011 of R4.9 million (2009: R2.2    
million). The significant improvement in Jasco`s performance was influenced     
by the acquisition and integration of Spescom during the first quarter in       
2011, and a significant restructuring of the business for growth. Further       
information on Jasco`s earnings, operations and prospects are available on      
SENS under JSE Code: JSC.                                                       
AfroCentric`s exploration and prospecting projects with Rio Tinto Plc           
continue in terms of the Reciprocal Strategic Co-operation Agreement.           
Financial results                                                               
For the six month period ended 31 December 2011, earnings per share (EPS)       
increased by 16% to 20,48 cents (2010: 17,71 cents) and diluted EPS             
increased by 15% to 17,39 cents (2010: 15,06 cents). Headline earnings per      
share (HEPS) increased by 13% to 20,37 cents (2010: 18,09 cents) and diluted    
HEPS increased by 12% to 17,29 cents (2010: 15,38 cents).                       
Prospects                                                                       
The Board maintains a regular review of the activities of the group`s           
current investment portfolio. The Board is satisfied with the progress in       
each case and given the gradual improvement in market conditions and            
confidence, will continue to assess opportunities which satisfy the criteria    
of the Board Investment Committee.                                              
Subsequent events                                                               
No significant events have occurred in the period between the reporting date    
and the date of this announcement.                                              
Directors                                                                       
There were no changes in the constitution of the Board of Directors during      
the period under review.                                                        
Dividends                                                                       
The policy of the Board is to review profits available for distribution to      
shareholders at the end of each financial year. Accordingly no distribution     
has been considered at this time.                                               
By Order of the Board                                                           
MI Sacks CA (SA) AICPA (ISR)                                                    
Company secretary                                                               
Johannesburg                                                                    
Directors                                                                       
NB Bam** (Chairperson), JM Kahn**, M I Sacks**#, B Joffe**,                     
MJ Madungundaba**, AT Mokgokong**, WRC Holmes, GL Napier*, Y Masithela*         
* independent non-executive, ** non-executive, # company secretary              
Registered Office                                                               
37 Conrad Road                                                                  
Florida North 1709                                                              
14 March 2012                                                                   
Sponsor                                                                         
Sasfin Capital                                                                  
(A division of Sasfin Bank Limited)                                             
www.afrocentric.za.com                                                          
Date: 14/03/2012 17:43:01 Produced by the JSE SENS Department.                  
The SENS service is an information dissemination service administered by the    
JSE Limited (`JSE`). The JSE does not, whether expressly, tacitly or            
implicitly, represent, warrant or in any way guarantee the truth, accuracy or   
completeness of the information published on SENS. The JSE, their officers,     
employees and agents accept no liability for (or in respect of) any direct,     
indirect, incidental or consequential loss or damage of any kind or nature,     
howsoever arising, from the use of SENS or the use of, or reliance on,          
information disseminated through SENS.
Profile Group (Pty) Ltd. has taken care in preparing all information on this website, but does not accept any liability for errors or out-of-date information.
Other Profile Group sites: FundsData Online (unit trust data)  |  Profile Group corporate site
Terms of Use |  Privacy Policy |  PAIA manual |  FAQs/Help |  Site Map |  © Copyright Reserved 2026  ]
  


Powered by ProfileData

Profile Mobile App Google Play Store Apple App Store


Follow us on: